Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.

Leukemia & lymphoma - 1 Oct 2007

Lee Je-Jung, Choi Bo-Hwa, Kang Hyun-Kyu, Park Myong-Suk, Park Jung-Sun, Kim Sang-Ki, Pham Thanh-Nhan Nguyen, Cho Duck, Nam Jong-Hee, Kim Young-Jin, Rhee Joon-Haeng, Yang Deok-Hwan, Kim Yeo-Kyeoung, Kim Hyeoung-Joon, Chung Ik-Joo

Abstract excerpt

We investigated the possibility of immunotherapy for multiple myeloma (MM) using myeloma-specific cytotoxic T lymphocytes (CTLs) that were stimulated in vitro by dendritic cells (DCs) pulsing with purified and optimized myeloma lysates. CD14(+) cells were cultured in the presence of GM-CSF and IL-4. On day 6, the immature DCs were pulsed with the purified myeloma cell lysates, and then maturation of the DCs was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytotoxicity, Immunologic
Share to Granulocyte-Macrophage Colony-Stimulating Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interleukin-4

Share to K562 Cells

Share to Lipopolysaccharide Receptors

Share to Lymphocyte Culture Test, Mixed

Share to Multiple Myeloma

Share to Syndecan-1

Source

Identifiers

PMID: 17917970
DOI: 10.1080/10428190701583975

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of multiple myeloma-specific cytotoxic T lymphocyte stimulation by dendritic cell pulsing with purified and optimized myeloma cell lysates.PMID 17917970Read ↗

Successful cross-presentation of allogeneic myeloma cells by autologous alpha-type 1-polarized dendritic cells as an effective tumor antigen in myeloma patients with matched monoclonal immunoglobulins.Semantic proximity Read ↗

Ex vivo induction of multiple myeloma-specific cytotoxic T lymphocytes.Semantic proximity Read ↗

Impaired functionality and phenotypic profile of dendritic cells from patients with multiple myeloma.Semantic proximity Read ↗

Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy.Semantic proximity Read ↗

Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.Semantic proximity Read ↗

Dendritic cells generated from the blood of patients with multiple myeloma are phenotypically and functionally identical to those similarly produced from healthy donors.Semantic proximity Read ↗

Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components.Semantic proximity Read ↗

Enhancement of clonogenicity of human multiple myeloma by dendritic cells.Semantic proximity Read ↗

Identification and characterization of HLA-A24-specific XBP1, CD138 (Syndecan-1) and CS1 (SLAMF7) peptides inducing antigens-specific memory cytotoxic T lymphocytes targeting multiple myeloma.Semantic proximity Read ↗

Dendritic cells mediate the induction of polyfunctional human IL17-producing cells (Th17-1 cells) enriched in the bone marrow of patients with myeloma.Semantic proximity Read ↗

Induction of leukemic-cell-specific cytotoxic T lymphocytes by autologous monocyte-derived dendritic cells presenting leukemic cell antigens.Semantic proximity Read ↗

Sperm protein 17 (Sp17) in multiple myeloma: opportunity for myeloma-specific donor T cell infusion to enhance graft-versus-myeloma effect without increasing graft-versus-host disease riskSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.